By Drug Target Review2025-08-21T01:30:03
Researchers at UC San Diego have discovered a graphene-based technology that accelerates the maturation of human brain organoids, offering a safer, non-invasive way to model diseases like Alzheimer’s.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-06-29T09:19:53
Sponsored by BMG Labtech GmbH
2023-07-04T10:05:58
Sponsored by Revvity
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2023-02-07T15:25:20
Sponsored by Bio-Techne
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud